GeneDx reports GUARDIAN genomic newborn screening study enrolls 30,000 infants, with 72.3% participation rate

Bitget2026/10/07 12:32

GeneDx flagged new evidence supporting genomic newborn screening, with study updates set for presentation at ICoNS on Oct. 7-8 in Boston. GUARDIAN study results indicated strong enrollment, consistent performance across diverse ancestries, meaningful clinical findings, alongside existing newborn screening. Screening also surfaced actionable inherited cardiac-risk cases, prompting preventive treatment in infants, with follow-on testing identifying at-risk relatives. BRIDGES-NBS, a nationwide NIH-funded initiative, is scheduled to start enrolling this month to test multi-state rollout inside public screening programs. Program design targets early-life treatable conditions, positioning GeneDx to support broader clinical adoption if feasibility and outcomes hold. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261007662968) on October 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Alcoa (AA.US) reported third-quarter revenue of $3.7 billion, up nearly 24% year-on-year.

Alcoa reported its financial results for the third quarter of 2026 on Thursday, showing a revenue of 3.704 billion USD for the quarter.

智通财经•2026/10/15 22:36

BUZZ - Morningstar maintains fair value estimate for Aurora Australiana due to strong performance in its canning business

路透社•2026/10/15 22:26

BUZZ - Citi remains cautious about the revival of ARB, while Morningstar is optimistic about its value

路透社•2026/10/15 22:21

Updated version 3 - KFC selects Coca-Cola as its soda supplier in the United States, ending its long-term partnership with Pepsi.

路透社•2026/10/15 22:06